Let's see a peer - reviewed paper showing ANY population ANYWHERE living into its 90s and 100s on low - carb, or a low - carb Ornish who reversed CVD or diabetes or cancer and documented the reversal with follow - up angiograms, PSAs, imaging
showing tumor regression, etc..
Not exact matches
Blood testing
showed an expansion in the numbers of CD19 - targeted CAR T - cells that coincided with the
tumor's
regression.
Results of a phase one trial
show that an investigational topical drug, resiquimod gel, causes
regression of both treated and untreated
tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL)-- a rare type of non-Hodgkin lymphoma that affects the skin.
In 2010, CRI researchers Drew Pardoll, M.D., Ph.D., Susan Topalian, M.D., and colleagues completed a phase I study
showing that a PD -1-specific monoclonal antibody induces frequent
tumor regressions in patients with advanced melanoma, renal cancer, lung cancer, and colon cancer with very low rates of toxicity.
Slow down lymphoma growth modestly and
show no effect on
tumor regression; delay
tumor recurrence with activation of p53; enhance
tumor regression and inhibit
tumor recurrence after alkylating drug therapy.